Overview
Key stats
Fundamentals Sep 9- Open
- $73.23
- 52-wk high
- $80.97
- High
- $74.60
- 52-wk low
- $32.57
- Low
- $72.25
- Prev close
- $74.67
- Mkt cap
- $6.51B
- Volume
- 550.8K
- Beta
- 0.24
- P/S
- 1044.7x
- P/B
- 6.4x
- Profit margin
- +0.0%
- Op margin
- -7468.0%
- ROE
- -26.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 31.5% below what analysts expected.
Earnings per share
-$0.54 expected
What the street expects next
EPS expected
-$0.96 to -$0.66
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.7M | $2.3M | $1.1M | $1.2M |
| Cost of what it sold | $1.6M | $2.9M | $3.0M | $3.9M |
| Gross profit | $89.0K | -$592.0K | -$1.9M | -$2.8M |
| What it spent | ||||
| Research and development | $27.9M | $30.0M | $43.7M | $54.7M |
| Sales and admin | $23.3M | $18.0M | $20.8M | $29.0M |
| Total operating expenses | $51.2M | $48.1M | $64.5M | $83.6M |
| What was left | ||||
| Operating profit | -$51.1M | -$48.7M | -$66.4M | -$86.4M |
| Profit before tax | -$43.8M | -$41.3M | -$60.2M | -$79.1M |
| Net profit | -$43.8M | -$41.3M | -$60.2M | -$79.1M |
| EBITDA | -$43.4M | -$40.5M | -$59.4M | -$79.1M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Bank of New York Mellon Corp Invests $16.58 Million in CG Oncology, Inc. $CGON
Leans bullishSep 1CG Oncology, Inc. $CGON Shares Sold by Wellington Management Group LLP
NeutralAug 31Man Group plc Takes $3.68 Million Position in CG Oncology, Inc. $CGON
NeutralAug 31California loses another multibillion-dollar company to Texas
Leans bullishAug 31CG Oncology, Inc. $CGON Shares Purchased by Algert Global LLC
NeutralAug 29BlackRock Inc. Buys New Shares in CG Oncology, Inc. $CGON
Leans bullishAug 28ADAR1 Capital Management LLC Invests $8.43 Million in CG Oncology, Inc. $CGON
NeutralAug 26Another California giant bolts for Texas as multi-billion-dollar company announces move
BullishAug 26